Given the observations that radiosensitization through incremental DNA damage on tumor cells is highly related to NPC remission,[10] we performed clonogenic assays to investigate if manipulating RPA1 has any effect on the radiosensitivity of NPC cells. The gene discussed is RPA1; the disease is nasopharyngeal carcinoma.